Kungasiza Ngesifo Sohudo Nokuningi
I-Saccharomyces boulardii uhlobo lomvubelo olususwe esikhumbeni sezitshalo ezifana ne-lychee ne-mangosteen. Sekuyisikhathi eside esetshenziselwa ezinye izinhlelo zemithi futhi manje etholakalayo kwifomu yokuxhaswa kokudla, iSaccharomyces boulardii kucatshangwa ukuthi iyasiza ekwelapheni izinkinga ezihlukahlukene zamathumbu.
I-Saccharomyces boulardii ibhekwa njenge- probiotic , isigaba sama-bacteria azuzisayo atholakele ukuvuselela amasosha omzimba nokuvikela impilo yokugaya.
Ukusetshenziswa
Ngokwelashwa okunye, uSaccharomyces boulardii kuthiwa usize ngezimo ezilandelayo zomzimba:
- Isifo sikaCrohn
- isifo sohudo
- isifo sofuba esiswini
- i-ulcerative colitis
Nakuba i-Saccharomyces boulardii isetshenziswa njengendlela yokwelapha izinkinga zamathumbu, abanye abantu bayayisebenzisela izinkuni, izilonda zokuxosha, i-cholesterol ephakeme, izifo zokungena emanzini, nezifo zesilonda.
Izinzuzo zezeMpilo
I-Saccharomyces boulardii ingasiza ekwelapheni kanye / noma ekuvimbeleni ukukhathazeka okuthile kwamathumbu, ngokusho kombiko oshicilelwe kuyi- World Journal of Gastroenterology ngo-2010. Ngokombiko, uphenyo uhlaziye izivivinyo zokwelapha ezingama-27 ezihlola ukusetshenziswa kweSacromromes boulardii ngezifo ezihlukahlukene. Bathola ubufakazi obubalulekile bokuthi iSaccharomyces boulardii ingasiza ukuvimbela kokubili isifo sohudo nesifo sohudo esihlobene nokusetshenziswa kwama- antibiotics .
Ngaphezu kwalokho, lo mbiko ubonisa ukuthi uSaccharomyces boulardii ubonisa isithembiso ekwelapheni isifo sofuba esiswini , isifo sohudo esidala, nesifo sikaCrohn .
Kodwa-ke, abalobi bathi ukucwaninga okwengeziwe kuyadingeka ngaphambi kokuthi uSaccharomyces boulardii inconywe ngalezi zimo.
Kukhona nobufakazi bokuthi iSaccharomyces boulardii ingasiza ekunakekeleni i-ulcerative colitis. Ngokwesibonelo, isifundo sezindiza esanyatheliswa kuyi- European Journal ye-Gastroenterology ne-Hepatology ngo-2003 sathola ukuthi iziguli ezine- ulcerative colitis zingase zizuze ekusebenziseni i-Saccharomyces boulardii ehlangene nemeszine (isidakamizwa esivimba ukuvuvukala esetshenziselwa ukwelapha isifo sofuba esiswini).
Ukuze kuhlolwe, iziguli ezingu-25 ezine-mild-to-moderate-up of ulcerative colitis zathatha iSchacharomyces boulardii kathathu ngosuku amaviki amane ngesikhathi sokwelashwa nge-mesalazine. Kulezi ziguli ezingama-24 eziqedile ukutadisha, abangu-17 bebengene ekupheleni kokuphela kwesifundo.
I-Saccharomyces boulardii ingasiza futhi ukuphatha isifo sohudo esiphuthumayo entsheni, ngokusho kocwaningo lwango-2011 olwanyatheliswa kuyi- Journal of Pediatric Gastroenterology and Nutrition . Lolu cwaningo lwabandakanya izingane ezingu-186 ezibhedlela esibhedlela zingakapheli amahora angu-72 emva kokuqala kwesifo sohudo oluvuthiwe, ngamunye wabo owathola iSaccharomyces boulardii noma i-placebo izinsuku ezinhlanu. Phakathi kwezinsana ezingu-176 eziqedile lolu cwaningo, labo abaphathwa nge-Saccharomyces boulardii babenesikhathi esifushane kakhulu sohudo (uma kuqhathaniswa namalungu eqembu le-placebo).
Amapulangwe
Njengamanye ama-supplement, kancane kuyaziwa ngokuphepha kokusebenza isikhathi eside noma okujwayelekile ngenxa yokungabi ncwaningo.
I-Saccharomyces boulardii ingabangela imiphumela eminye yemiphumela (njengegesi nokuqhakaziza). Ngaphezu kwalokho, kunokukhathazeka okuthile ukuthi ukusetshenziswa kwe-Saccharomyces boulardii kungaholela ekufungemia (isimo esiboniswe ngokuba khona kwefungi egazini). Abantu abadala, izinsana, iziguli ezingenakuzivikela noma ezigula kakhulu, kanye nabantu abane-colitis, umdlavuza, ama-catheters angama-central, nanoma yisiphi isimo esingavamile noma esiyingozi kufanele bagweme iSaccharomyces boulardii, noma bayisebenzise kuphela ngemva kokubonisana nomhlinzeki wabo oyinhloko.
Njengoba i-Saccharomyces boulardii iyimvubelo, abantu abanezinyosi zokudla okunomvubelo bayelulekwa ukuba bagweme ukusetshenziswa kwayo.
Khumbula ukuthi ama-supplements awazange ahlolwe ukuphepha kanye nezindleko zokudla ngokuyinhloko ezingavunyelwe ngokomthetho. Kwezinye izimo, umkhiqizo ungase ulethe ukulinganisa okungafani nesilinganiso esicacisiwe semifino ngayinye. Kwezinye izimo, umkhiqizo ungangcoliswa nezinye izinto ezifana nezensimbi. Futhi, ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo azange zisungulwe.
Lapho Uzoyithola khona
Etholakala kakhulu ukuthengwa ku-intanethi, izithako eziqukethe i-Saccharomyces boulardii zithengiswa ezitolo eziningi zemvelo, ezitolo zokuthengisa izidakamizwa kanye nezitolo ezikhethekile ezisekelweni zokudla.
Ukusebenzisa i-Saccharomyces Boulardii yezeMpilo
Ngenxa yokucwaninga okulinganiselwe, kusheshe ukuba batusa uSchachayyces boulardii njengokwelashwa nganoma yisiphi isimo. Kubalulekile futhi ukuqaphela ukuthi ukuzitholela isimo futhi ukugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi. Uma ucabangela ukuyisebenzisa nganoma iyiphi injongo yezempilo, qiniseka ukuthi uqale uthintane nodokotela wakho kuqala.
> Imithombo:
I-Berni Canani R, i-Cucchiara S, i-Cuomo R, i-Pace F, i-Papale F. "I-Saccharomyces boulardii: isifingqiso sobufakazi bokusebenza kwemithi yesifo somzimba kubantu abadala nabantwana." I-Eur Rev Med Pharmacol Sci. 2011 Jul; 15 (7): 809-22.
I-Corrêa NB, uPenna FJ, i-Lima FM, uNicoli JR, i-Filho LA. "Ukwelashwa kwesifo sohudo esinamandla ne-Saccharomyces boulardii ezinsaneni." I-Pediatr Gastroenterol Nutriti. 2011 Nov; 53 (5): 497-501.
UGuslandi M, Giollo P, Testoni PA. "Isivivinyo somshayeli we-Saccharomyces boulardii e-ulcerative colitis". "Eur J Gastroenterol Hepatol. 2003 Jun; 15 (6): 697-8.
Im E, Pothoulakis C. "Ukuthuthukiswa kwamuva ku-Saccharomyces boulardii ucwaningo." I-Gastroenterol Clinic Biol. 2010 Sep; 34 Ukusekela 1: S62-70.
I-Kelesidis T, i-Pothoulakis C. "Ukusebenza nokuphepha kwe-probiotic Saccharomyces boulardii yokuvimbela nokwelapha kwezinkinga zamathunjini." I-Therap Adv Gastroenterol. 2012 Mar; 5 (2): 111-25.
McFarland LV. "Ukubuyekezwa kwesistimu nokuhlaziywa kwe-Saccharomyces boulardii kuziguli ezikhulile." I-World J Gastroenterol. 2010 Meyi 14; 16 (18): 2202-22.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.